Pharmacotherapeutic considerations for chronic pain in chronic kidney and end-stage renal disease
Open Access
- 1 December 2016
- journal article
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 9, 1191-1195
Abstract
Pharmacotherapeutic considerations for chronic pain in chronic kidney and end-stage renal disease Roy O Mathew,1 Jeffrey J Bettinger,2 Erica L Wegrzyn,3 Jeffrey Fudin3,4 1Department of Medicine, Wm. Jennings Bryan Dorn VA Medical Center, Columbia, SC, 2Department of Professional Practice, Albany College of Pharmacy and Health Sciences, 3Department of Pharmacy, Albany Stratton VA Medical Center, Albany, 4Scientific and Clinical Affairs, Remitigate, LLC, Delmar, NY, USAIn hemodialysis (HD) patients, the prevalence of chronic pain can be up to 92%.1 A survey of HD patients found 55% reported a severe pain episode in the previous 24 hours.2 Furthermore, ~75% of HD patients report inadequate pain management.2 Despite these shocking statistics there is no universally accepted guideline for the treatment of pain in HD patients. Nevertheless, poorly managed pain in HD patients promulgates psychological disturbances, impaired sleep, decreased dialysis compliance, and an overall decline in quality of life.1Keywords
This publication has 25 references indexed in Scilit:
- Prevalence and severity of pain in adult end-stage renal disease patients on chronic intermittent hemodialysis: a systematic reviewPatient Preference and Adherence, 2016
- American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older AdultsJournal of the American Geriatrics Society, 2015
- Effects of chronic kidney disease and uremia on hepatic drug metabolism and transportKidney International, 2014
- Antidepressants for depression in stage 3–5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP)*Nephrology Dialysis Transplantation, 2012
- Effects of Varying Degrees of Renal Impairment on the Pharmacokinetics of DuloxetineClinical Pharmacokinetics, 2010
- Altered nonrenal drug clearance in ESRDCurrent Opinion in Nephrology and Hypertension, 2008
- Drug Dosing in Chronic Kidney DiseaseMedical Clinics of North America, 2005
- Lifetime Nonnarcotic Analgesic Use and Decline in Renal Function in WomenArchives of internal medicine (1960), 2004
- Clinical Pharmacokinetics of Antibiotics in Patients with Impaired Renal FunctionClinical Pharmacokinetics, 1992
- Alteration of Drug-Protein Binding in Renal DiseaseClinical Pharmacokinetics, 1984